Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Silent genetic alterations identified by targeted next-generation sequencing in pheochromocytoma/paraganglioma: A clinicopathological correlations.

Experimental and molecular pathology - 1 Feb 2017

Pillai Suja, Gopalan Vinod, Lo Chung Y, Liew Victor, Smith Robert A, Lam Alfred King Y

Abstract excerpt

AIMS: The goal of this pilot study was to develop a customized, cost-effective amplicon panel (Ampliseq) for target sequencing in a cohort of patients with sporadic phaeochromocytoma/paraganglioma. METHODS: Phaeochromocytoma/paragangliomas from 25 patients were analysed by targeted next-generation sequencing approach using an Ion Torrent PGM instrument. Primers for 15 target genes (NF1, RET, VHL, SDHA, SDHB,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Germ-Line Mutation
Share to High-Throughput Nucleotide Sequencing

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Kinesins

Share to Neurofibromin 1

Share to Paraganglioma

Share to Pheochromocytoma

Share to Pilot Projects

Share to Succinate Dehydrogenase

Source

Identifiers

PMID: 27986441
DOI: 10.1016/j.yexmp.2016.12.007

Genes

EPAS1
MAX
MEN1
RET
SDHA
SDHAF2
SDHB
SDHC
SDHD
VHL

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026. Manifest publication-graph-cohort-2026-09-05.1.

Source receipt: pubmed, retrieved 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Silent genetic alterations identified by targeted next-generation sequencing in pheochromocytoma/paraganglioma: A clinicopathological correlations.PMID 27986441Read ↗

Rare germline mutations identified by targeted next-generation sequencing of susceptibility genes in pheochromocytoma and paraganglioma.Semantic proximity Read ↗

Clinical exome next‑generation sequencing panel for hereditary pheochromocytoma and paraganglioma diagnosisSemantic proximity Read ↗

Whole Exome Sequencing Identifies Novel Genetic Alterations in Patients with Pheochromocytoma/Paraganglioma.Semantic proximity Read ↗

Integrative genomic analysis reveals somatic mutations in pheochromocytoma and paraganglioma.Semantic proximity Read ↗

Germline genetic variants in pheochromocytoma/paraganglioma: single-center experienceSemantic proximity Read ↗

Whole exome sequencing is an efficient and sensitive method for detection of germline mutations in patients with phaeochromcytomas and paragangliomas.Semantic proximity Read ↗

Next-generation sequencing in the clinical genetic screening of patients with pheochromocytoma and paragangliomaSemantic proximity Read ↗

Genetics of pheochromocytoma and paraganglioma.Semantic proximity Read ↗

Updates on the genetics and the clinical impacts on phaeochromocytoma and paraganglioma in the new eraSemantic proximity Read ↗

A comprehensive next generation sequencing-based genetic testing strategy to improve diagnosis of inherited pheochromocytoma and paraganglioma.Semantic proximity Read ↗

Integrative genetic characterization and phenotype correlations in pheochromocytoma and paraganglioma tumours.Semantic proximity Read ↗

The genetics of phaeochromocytoma: using clinical features to guide genetic testing.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.